Richard J. Knight, MD

Professor of Surgery, Institute for Academic Medicine
Houston Methodist
Weill Cornell Medical College


Education & Training

Residency, Mount Sinai Medical Center
Clinical Fellowship, University of Texas Medical School at Houston
MD, Tulane University
Internship, Mount Sinai Medical Center
Publications

De Novo DSA in the Setting of Stable Renal Allograft Function is a Benign Finding
Knight, RJ, Eagar, TN, Nguyen, DTM, Graviss, EA, Kuten, SA, Patel, SJ, Moore, LW & Gaber, AO 2018, 27th International Congress of The Transplantation Society, Madrid, Spain, 6/30/18 - 7/5/18, .

Short- and midterm results for internal jugular vein extension for short right renal vein kidney transplant
Lu, T, Yi, SG, Bismuth, J, Knight, RJ, Gaber, AO & Bechara, CF 2018, Clinical Transplantation, vol. 32, no. 8, e13312, pp. e13312. DOI: 10.1111/ctr.13312

Ciprofloxacin for BK Viremia Prophylaxis in Kidney Transplant Recipients: Results of a Prospective, Randomized Controlled Trial
Patel, SJ, Nguyen, DTM, Graviss, EA, Nolte, JV, Agboli, I, Moore, LW, Kuten, SA, Pham, C, Gaber, AO & Knight, RJ 2018, 2018 American Transplant Congress (ATC), Seattle, United States, 6/2/18 - 6/6/18, .

Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia
Knight, RJ, Graviss, EA, Nguyen, DT, Kuten, SA, Patel, SJ, Gaber, L & Gaber, AO 2018, Clinical Transplantation, pp. e13265. DOI: 10.1111/ctr.13265

Unexplained fever after pancreas transplantation
Klasek, R, Kuten, SA, Patel, SJ, Graviss, EA, Nguyen, DT, Hobeika, MJ, Gaber, OA, Podder, H & Knight, RJ 2018, Clinical Transplantation, pp. e13351. DOI: 10.1111/ctr.13351

A Cross-sectional Evaluation of the Relationship Between Vitamin D Status and Supplement Use Across Levels of Kidney Function in Adults: Vitamin D Status, Supplements, and Kidney function
Moore, LW, Suki, WN, Lunsford, KE, Sabek, O, Knight, RJ & Gaber, AO 2018, BMJ.

Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction
Kuten, SA, Patel, SJ, Baru, A, Gaber, AO, Crutchley, RD, Ramanathan, V & Knight, RJ 2017, Transplant Infectious Disease, vol. 19, no. 5, e12748. DOI: 10.1111/tid.12748

Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation
Islam, AK, Sinha, N, DeVos, JM, Kaleekal, TS, Jyothula, SS, Teeter, LD, Nguyen, DTM, Eagar, TN, Moore, LW, Puppala, M, Wong, STC, Knight, RJ, Frost, AE, Graviss, EA & Osama Gaber, A 2017, Clinical Transplantation. DOI: 10.1111/ctr.13028

Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients
Patel, SJ, Kuten, SA, Knight, RJ, Graviss, EA, Nguyen, DTM & Gaber, AO 2017, . in Clinical Transplants 2016. Terasaki Research Institute, Los Angeles, California, pp. 103-109.

BK virus as a mediator of graft dysfunction following kidney transplantation
Yi, SG, Knight, RJ & Lunsford, KE 2017, Current Opinion in Organ Transplantation. DOI: 10.1097/MOT.0000000000000429

Neurogenic Orthostatic Hypotension: An Iatrogenic Complication of Successful Pancreas Transplantation?
Kuten, SA, Simpson, EP, Gaber, AO, Nguyen, DTM, Graviss, EA, Patel, S & Knight, RJ 2017, .

The Incidence and Outcomes of Fever of Unknown Origin After Pancreas Transplantation
Klasek, R, Kuten, SA, Patel, S, Nguyen, DT, Graviss, EA, Gaber, AO & Knight, RJ 2017, American Journal of Transplantation, vol. 17, no. suppl 3, 17 (suppl 3).

The detrimental impact of persistent vs an isolated occurrence of de novo donor-specific antibodies on intermediate-term renal transplant outcomes
Loucks-DeVos, JM, Eagar, TN, Gaber, AO, Patel, SJ, Teeter, LD, Graviss, EA & Knight, RJ 2017, Clinical Transplantation, vol. 31, no. 8. DOI: 10.1111/ctr.13025

Combination Drug Products for HIV—A Word of Caution for the Transplant Clinician
Patel, SJ, Kuten, SA, Musick, WL, Gaber, AO, Monsour, HP & Knight, R 2016, American Journal of Transplantation, vol. 16, no. 8, pp. 2479-2482. DOI: 10.1111/ajt.13826

Intermediate-Term Outcomes of Dual Adult versus Single-Kidney Transplantation: Evolution of a Surgical Technique
Islam, AK, Knight, RJ, Mayer, WA, Hollander, AB, Patel, S, Teeter, LD, Graviss, EA, Saharia, A, Podder, H, Asham, EH & Gaber, AO 2016, The Journal of Heart Transplantation, vol. 2016, pp. 2586761. DOI: 10.1155/2016/2586761

Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction
Patel, SJ, Suki, WN, Loucks-DeVos, J, Graviss, EA, Nguyen, DT, Knight, RJ, Kuten, SA, Moore, LW, Teeter, LD, Gaber, LW & Gaber, AO 2016, Transplant International, vol. 29, no. 8, pp. 897-908. DOI: 10.1111/tri.12791

Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients
Patel, SJ, Kuten, SA, Knight, RJ, Graviss, EA, Nguyen, D & Gaber, AO 2016, Clinical transplants, vol. 32, pp. 103-109.

Excessive Weight Gain After Pancreas Transplant: Transitioning from Type 1 to Type 2 Diabetes?
Islam, AK, Lawless, A, Teeter, LD, Graviss, E, Victor, III, DW, Sadhu, A, Patel, SJ, Gaber, AO & Knight, R 2015, American Journal of Transplantation, vol. 2015, no. 15 (suppl3), 2015; 15.

Barriers to preemptive renal transplantation: a single center questionnaire study
Knight, RJ, Teeter, LD, Graviss, EA, Patel, SJ, DeVos, JM, Moore, LW & Gaber, AO 2015, Transplantation, vol. 99, no. 3, pp. 576-579. DOI: 10.1097/TP.0000000000000357

Observations on the use of cidofovir for BK virus infection in renal transplantation
Kuten, SA, Patel, SJ, Knight, RJ, Gaber, LW, Devos, JM & Gaber, AO 2015, Transplant Infectious Disease, vol. 16, no. 6, pp. 975-983. DOI: 10.1111/tid.12313